Fourth Quarter 2024 Financial Results Total revenue in the fourth quarter of 2024 grew 19% to $21.5 million, compared with $18.0 million in the fourth quarter of 2023. The Company’s revenue growth was ...

Cassava's strong liquidity with $128.6 million in cash supports early-stage development, yet long-term funding needs may lead ...

Financially stable with $469.5 million in cash, Praxis Precision Medicines can fund operations until 2028. Read why my rating on PRAX stock remains as a "Hold".

Epilepsy, a misunderstood neurological disorder, affects millions worldwide, but with proper treatment, individuals can lead ...

Advancements in medical technology have led to the development of an artificial intelligence tool named MELD Graph, which can detect brain lesions associated with epilepsy that are often missed by ...

It was trained to detect focal cortical dysplasia (FCD), malformations that happen when neurons do not develop properly in ...

One in five epilepsy patients has uncontrolled seizures due to brain abnormalities too subtle for doctors to spot.

Scientists have developed an AI-powered tool that detects 64% of brain abnormalities linked to epilepsy that human ...

Epilepsy is a complex disorder with both obvious and hidden symptoms, and some individuals are at a higher risk due to ...

The drug fenfluramine has been recommended by the National Institute for Health and Care Excellence (NICE) for children with ...

Join the epilepsy community for Purple Day® on March 26, a global initiative to raise epilepsy awareness and support the millions of people living with epilepsy worldwide. Approximately 65 million ...